Results 251 to 260 of about 47,219,118 (367)
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source
International Learning Initiative Part 2: Enhancing Antiracism Awareness Among Nursing Students in Sweden and the USA. [PDF]
Odzakovic E+6 more
europepmc +1 more source
Researches upon the venoms of poisonous serpents / by S. Weir Mitchell and Edward T. Reichert.
S. Weir Mitchell, Edward Tyson Reichert
openalex +2 more sources
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias+12 more
wiley +1 more source
Ambivalence towards food, healthy eating and the role of self-compassion. [PDF]
Kuijer RG, Tunley MK.
europepmc +1 more source